Figure 7
Figure 7. sdAb19 reverses Nef effects on peripheral CD4+ T cells in vivo. Peripheral lymph nodes were analyzed 4-5 months after reconstitution, gating on donor (CD45.1+) cells. Gating of GFP−, GFPhi, and GFPlow cells was based on distribution of cell populations with distinct GFP intensities as well as levels of CD4 in Tg sdAb19+ chimeras. (A) Average CD4 MFI on pLN CD4+ T cells was compared with the average CD4 MFI found on CD4+ T cells in non-Tg chimeras. CD4 MFI in Tg GFP− cells was determined on CD4low cells. (B) Average percentage of cells expressing CD44 or CD25 among pLN CD4+ T cells showing CD4 and GFP high or low levels or among CD4low T cells in chimeras reconstituted with uninfected Tg fetal liver. (C) Percentage of GFPhi and GFPlow cells within designated subsets. Statistical analysis was performed with the Student t test (*P < .5, **P < .01, and ***P < .001; ns indicates not significant). Error bars represent 1 SD from the mean.

sdAb19 reverses Nef effects on peripheral CD4+ T cells in vivo. Peripheral lymph nodes were analyzed 4-5 months after reconstitution, gating on donor (CD45.1+) cells. Gating of GFP, GFPhi, and GFPlow cells was based on distribution of cell populations with distinct GFP intensities as well as levels of CD4 in Tg sdAb19+ chimeras. (A) Average CD4 MFI on pLN CD4+ T cells was compared with the average CD4 MFI found on CD4+ T cells in non-Tg chimeras. CD4 MFI in Tg GFP cells was determined on CD4low cells. (B) Average percentage of cells expressing CD44 or CD25 among pLN CD4+ T cells showing CD4 and GFP high or low levels or among CD4low T cells in chimeras reconstituted with uninfected Tg fetal liver. (C) Percentage of GFPhi and GFPlow cells within designated subsets. Statistical analysis was performed with the Student t test (*P < .5, **P < .01, and ***P < .001; ns indicates not significant). Error bars represent 1 SD from the mean.

Close Modal

or Create an Account

Close Modal
Close Modal